Literature DB >> 22197855

Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD.

Miriam B Vos1, Ryan Colvin, Patricia Belt, Jean P Molleston, Karen F Murray, Philip Rosenthal, Jeffrey B Schwimmer, James Tonascia, Aynur Unalp, Joel E Lavine.   

Abstract

OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children in the United States. Although changes in diet are often recommended to improve NAFLD, little is known regarding the influence of diet on histologic features of the disease. SUBJECTS AND METHODS: This was a prospective, cross-sectional registry-based study. Children (n = 149) enrolled in the multicenter nonalcoholic steatohepatitis (NASH) Clinical Research Network had demographic, anthropometric, clinical, laboratory, and histology data obtained, including the Block Brief Food Questionnaire. Subjects were grouped by presence or absence of steatohepatitis and grades of histologic features according to NASH Clinical Research Network criteria.
RESULTS: No significant differences were found between children with steatosis compared with steatohepatitis for fraction of energy from fat, carbohydrates, and protein. Sugar-sweetened beverage consumption was low and did not correlate with histologic features, although uric acid, a surrogate marker for fructose intake, was significantly increased in those with definite NASH (P = 0.008). For all groups, vitamin E consumption was insufficient compared with the recommended daily allowance. Median consumption of vitamin E was lower in children with higher grade of steatosis (8.4 vs 6.1 vs 6.9 for grades I, II, and III, respectively, P = 0.05). Those consuming less vitamin C had increased ballooning degeneration (P = 0.05).
CONCLUSIONS: Children with NAFLD have a diet that is insufficient in vitamin E and this may contribute to the pathophysiology of NAFLD. In children with NAFLD, reported sugar-sweetened beverage consumption is low; however, uric acid, which may reflect total fructose consumption, was significantly associated with NASH and should be further evaluated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22197855      PMCID: PMC3208079          DOI: 10.1097/MPG.0b013e318229da1a

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  30 in total

1.  Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study.

Authors:  J E Lavine
Journal:  J Pediatr       Date:  2000-06       Impact factor: 4.406

2.  Histopathology of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Cynthia Behling; Robert Newbury; Reena Deutsch; Caroline Nievergelt; Nicholas J Schork; Joel E Lavine
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

3.  Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children.

Authors:  Joel E Lavine; Jeffrey B Schwimmer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-02       Impact factor: 2.839

4.  Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study.

Authors:  Jae Woong Lee; Yong Kyun Cho; Mc Ryan; Hyang Kim; Seung Won Lee; Eugene Chang; Kwan Joong Joo; Jung Tae Kim; Bum Soo Kim; Ki Chul Sung
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

Review 5.  Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism.

Authors:  Peter J Havel
Journal:  Nutr Rev       Date:  2005-05       Impact factor: 7.110

6.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

7.  Vitamin E treatment in pediatric obesity-related liver disease: a randomized study.

Authors:  Pietro Vajro; Claudia Mandato; Adriana Franzese; Edmondo Ciccimarra; Stefania Lucariello; Marcella Savoia; Grazia Capuano; Fiorella Migliaro
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-01       Impact factor: 2.839

8.  Are saturated fatty acids and insulin resistance associated with fatty liver in obese children?

Authors:  Dimitrios Papandreou; Israel Rousso; Pavlos Malindretos; Areti Makedou; Tatiana Moudiou; Ifigenia Pidonia; Athina Pantoleon; Ipolliti Economou; Ioannis Mavromichalis
Journal:  Clin Nutr       Date:  2008-01-30       Impact factor: 7.324

9.  Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women.

Authors:  Xiang Gao; Lu Qi; Ning Qiao; Hyon K Choi; Gary Curhan; Katherine L Tucker; Alberto Ascherio
Journal:  Hypertension       Date:  2007-06-25       Impact factor: 10.190

10.  The relationship between normal serum uric acid and nonalcoholic fatty liver disease.

Authors:  In-Cheol Hwang; Sang-Yeon Suh; Ah-Ram Suh; Hong-Yup Ahn
Journal:  J Korean Med Sci       Date:  2011-02-25       Impact factor: 2.153

View more
  43 in total

Review 1.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Authors:  Thomas Jensen; Manal F Abdelmalek; Shelby Sullivan; Kristen J Nadeau; Melanie Green; Carlos Roncal; Takahiko Nakagawa; Masanari Kuwabara; Yuka Sato; Duk-Hee Kang; Dean R Tolan; Laura G Sanchez-Lozada; Hugo R Rosen; Miguel A Lanaspa; Anna Mae Diehl; Richard J Johnson
Journal:  J Hepatol       Date:  2018-02-02       Impact factor: 25.083

2.  Estimation of fish and ω-3 fatty acid intake in pediatric nonalcoholic fatty liver disease.

Authors:  David E St-Jules; Corilee A Watters; Elizabeth M Brunt; Lynne R Wilkens; Rachel Novotny; Patricia Belt; Joel E Lavine
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-11       Impact factor: 2.839

Review 3.  Role of the diet as a link between oxidative stress and liver diseases.

Authors:  Teresa Arrigo; Salvatore Leonardi; Caterina Cuppari; Sara Manti; Angela Lanzafame; Gabriella D'Angelo; Eloisa Gitto; Lucia Marseglia; Carmelo Salpietro
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 4.  Pediatric nonalcoholic fatty liver disease: Prevalence, diagnosis, risk factors, and management.

Authors:  Stavra A Xanthakos; Rohit Kohli
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-09-25

5.  Vitamins and non-alcoholic fatty liver disease: A Molecular Insight.

Authors:  Sana Raza; Archana Tewari; Sangam Rajak; Rohit A Sinha
Journal:  Liver Res       Date:  2021-04-04

6.  Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats.

Authors:  Laura G Sanchez-Lozada; Ana Andres-Hernando; Fernando E Garcia-Arroyo; Christina Cicerchi; Nanxing Li; Masanari Kuwabara; Carlos A Roncal-Jimenez; Richard J Johnson; Miguel A Lanaspa
Journal:  J Biol Chem       Date:  2019-01-16       Impact factor: 5.157

7.  Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.

Authors:  Jeffrey C Sirota; Kim McFann; Giovanni Targher; Richard J Johnson; Michel Chonchol; Diana I Jalal
Journal:  Metabolism       Date:  2012-10-02       Impact factor: 8.694

8.  Association of vitamin E intake at early childhood with alanine aminotransferase levels at mid-childhood.

Authors:  Jennifer A Woo Baidal; Erika R Cheng; Sheryl L Rifas-Shiman; Emily Oken; Matthew W Gillman; Elsie M Taveras
Journal:  Hepatology       Date:  2018-03-01       Impact factor: 17.425

9.  Oral fructose absorption in obese children with non-alcoholic fatty liver disease.

Authors:  J S Sullivan; M T Le; Z Pan; C Rivard; K Love-Osborne; K Robbins; R J Johnson; R J Sokol; S S Sundaram
Journal:  Pediatr Obes       Date:  2014-06-24       Impact factor: 4.000

10.  Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON).

Authors:  Rohit Kohli; Shikha Sunduram; Marialena Mouzaki; Sabina Ali; Pushpa Sathya; Stephanie Abrams; Stavra A Xanthakos; Miriam Vos; Jeffrey B Schwimmer
Journal:  J Pediatr       Date:  2016-01-01       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.